BAX and cholangiocarcinoma: extended the apoptotic activity of USP8 in cholangiocarcinoma cells, where the silencing of USP8 was reported to decrease Bcl-2 expression and increase Bax, cleaved Caspase 3, and cleaved Caspase 9 expression and thereby triggering apoptosis (18).